These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37276843)

  • 1. Exacerbation of Intimal Fibrosis and Endarteritis in a Kidney Transplant Recipient with Chronic Active Antibody-Mediated Rejection and COVID-19: A Case Report.
    Otsuka T; Tanabe T; Hotta K; Iwasaki S; Tsuji T; Takahashi A; Takakuwa E; Shinohara N; Matsuno Y
    Nephron; 2023; 147 Suppl 1():41-45. PubMed ID: 37276843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effect of rabbit anti-thymocyte globulin for chronic active antibody-mediated rejection after kidney transplantation.
    Tanaka R; Tsutahara K; Inoguchi S; Horitani H; Asakura T; Kawamura N; Kakuta Y; Nakagawa M; Takao T
    CEN Case Rep; 2022 Feb; 11(1):79-83. PubMed ID: 34374932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSMP Is Discriminative for Chronic Active Antibody-Mediated Rejection and Associate With Intimal Arteritis in Kidney Transplantation.
    Zhan P; Li H; Han M; Wang Z; Zhao J; Tu J; Shi X; Fu Y
    Front Immunol; 2021; 12():661911. PubMed ID: 33897709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Active Antibody-Mediated Rejection Following COVID-19 Infection in a Kidney Transplant Recipient: A Case Report.
    Abuzeineh M; Tariq A; Rosenberg A; Brennan DC
    Transplant Proc; 2021 May; 53(4):1202-1206. PubMed ID: 33413879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic Kidney Transplantation After COVID-19: A Case Report.
    Kijima Y; Shimizu T; Sekido E; Kato S; Kano K; Toguchi M; Horiuchi T; Nozaki T; Omoto K; Inui M; Toma H; Iida S; Takagi T
    Transplant Proc; 2022; 54(6):1551-1553. PubMed ID: 34753590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
    Kutzler HL; Ye X; Rochon C; Martin ST
    Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymoglobulin-Resistant T-Cell-Mediated Acute Rejection in a Pregnant Renal Transplant Recipient: Case Report and Review of the Literature.
    Balaha M; Al-Otaibi T; Gheith OA; Halim MA; Shaker M; Fayyad Z; Nair P; Zakaria Z; Abo-Atya H; Makkeyia Y
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):159-163. PubMed ID: 30777545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report of COVID-19 Infection After Kidney Transplant Treated With Casirivimab-Imdevimab and Mycophenolate Mofetil Changed to Everolimus.
    Kijima Y; Shimizu T; Kato S; Kano K; Horiuchi T; Nozaki T; Omoto K; Inui M; Toma H; Iida S; Takagi T
    Transplant Proc; 2022; 54(6):1561-1563. PubMed ID: 35065832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).
    Streichart L; Felldin M; Ekberg J; Mjörnstedt L; Lindnér P; Lennerling A; Bröcker V; Mölne J; Holgersson J; Daenen K; Wennberg L; Lorant T; Baid-Agrawal S
    Trials; 2024 Mar; 25(1):213. PubMed ID: 38519988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.
    Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC
    Front Immunol; 2020; 11():1972. PubMed ID: 32983131
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated endarteritis and kidney transplant survival: a multicenter collaborative study.
    Sis B; Bagnasco SM; Cornell LD; Randhawa P; Haas M; Lategan B; Magil AB; Herzenberg AM; Gibson IW; Kuperman M; Sasaki K; Kraus ES;
    J Am Soc Nephrol; 2015 May; 26(5):1216-27. PubMed ID: 25381427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China.
    Zhu L; Gong N; Liu B; Lu X; Chen D; Chen S; Shu H; Ma K; Xu X; Guo Z; Lu E; Chen D; Ge Q; Cai J; Jiang J; Wei L; Zhang W; Chen G; Chen Z
    Eur Urol; 2020 Jun; 77(6):748-754. PubMed ID: 32317180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management.
    Chen TY; Farghaly S; Cham S; Tatem LL; Sin JH; Rauda R; Ribisi M; Sumrani N
    Transpl Infect Dis; 2020 Oct; 22(5):e13378. PubMed ID: 32573882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of nephrotic syndrome caused by recurrent IgA nephropathy with chronic active antibody-mediated rejection three years after kidney transplantation.
    Yaginuma T; Yamamoto H; Mitome J; Kobayashi A; Yamamoto I; Tanno Y; Hayakawa H; Miyazaki Y; Yokoyama K; Utsunomiya Y; Miki J; Yamada H; Furuta N; Yamaguchi Y; Hosoya T
    Clin Transplant; 2011 Jul; 25 Suppl 23():28-33. PubMed ID: 21623911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for the IMAGINE study for chronic active antibody-mediated rejection (caAMR) in kidney transplantation.
    Nickerson PW
    Am J Transplant; 2022 Dec; 22 Suppl 4():38-44. PubMed ID: 36453707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orosomucoid 1 is involved in the development of chronic allograft rejection after kidney transplantation.
    Higuchi H; Kamimura D; Jiang JJ; Atsumi T; Iwami D; Hotta K; Harada H; Takada Y; Kanno-Okada H; Hatanaka KC; Tanaka Y; Shinohara N; Murakami M
    Int Immunol; 2020 May; 32(5):335-346. PubMed ID: 31930291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.